National Path Lab
Autoimmune & Rheumatology

Rheumatoid Arthritis (RA)

Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects the joints. It occurs when the immune system mistakenly attacks the synovium — the lining of the joints — leading to inflammation, pain, and progressive joint damage if left untreated.
RA typically affects the small joints of the hands, wrists, and feet first, usually in a symmetric pattern (affecting both sides of the body similarly). Over time, without appropriate diagnosis and management, persistent inflammation may lead to joint deformity, reduced mobility, and impact on daily function.
At National Path Lab (NPL), laboratory investigations support the evaluation of suspected rheumatoid arthritis and help assess inflammatory activity, allowing your doctor to confirm diagnosis and guide treatment decisions.

Tests available
5
Tests available

Tests Available at NPL

RA (RHEUMATOID) FACTOR QUALITATIVE

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 350

ANTI CYCLIC CITRULLINATED PEPTIDE; ANTI CCP

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 2800

Mutated Citrullinated Vimentin (MCV) Antibody

Turn Around Time
SAMPLE BY MON/THU 8:00 AM REPORT ON SAME DAY EVENING

Rs. 5500

C-REACTIVE PROTEIN (CRP) QUANTITATIVE

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 800

ERYTHROCYTE SEDIMENTATION RATE; ESR

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 150

About Rheumatoid Arthritis (RA)

Causes & Risk Factors

The exact cause of RA is not fully understood, but it is believed to result from a combination of genetic susceptibility and environmental triggers that lead the immune system to attack joint tissue.

  • Genetic predisposition — certain genetic markers (such as HLA-DRB1) are associated with a higher risk of developing RA, particularly when combined with other risk factors.

  • Sex — RA is two to three times more common in women than in men, suggesting a hormonal influence on disease development.

  • Age — RA can begin at any age but most commonly starts between 30 and 60 years.

  • Smoking — one of the most significant modifiable risk factors; smoking increases both the risk of developing RA and disease severity.

  • Family history — having a close relative with RA or another autoimmune disease increases individual risk.

  • Obesity — associated with increased inflammatory burden and may influence disease onset and severity.

Symptoms & When to Test

RA symptoms often develop gradually over weeks to months, though some patients experience a more rapid onset.

  • Persistent joint pain, swelling, and tenderness — typically affecting small joints of the hands and feet first

  • Symmetric joint involvement — similar joints affected on both sides of the body

  • Morning stiffness lasting longer than one hour

  • Reduced joint mobility and grip strength

  • Fatigue and generalized malaise

  • Low-grade fever in some patients

  • Firm lumps under the skin (rheumatoid nodules) in longstanding disease

When Should You Consider Testing?

Testing is generally appropriate when joint symptoms persist for six weeks or longer, involve multiple joints, follow a symmetric pattern, or are accompanied by prolonged morning stiffness — particularly when a doctor is evaluating possible inflammatory arthritis rather than mechanical joint pain.

Why Tests Are Combined

No single test can confirm rheumatoid arthritis on its own. Anti-CCP and Rheumatoid Factor (RF) are antibody tests that support diagnosis, while CRP and ESR measure the degree of active inflammation rather than confirming the disease itself.

Some patients with RA test negative for RF (referred to as "seronegative" RA), which is why Anti-CCP — a more specific marker — is often tested alongside RF rather than in isolation.

Combining antibody testing with inflammatory markers gives your doctor both a diagnostic signal and a measure of current disease activity, which is valuable for both confirming RA and tracking response to treatment over time.

Tests Available at NPL

Test

Clinical Relevance

ANTI CYCLIC CITRULLINATED PEPTIDE; ANTI CCP

A relatively specific antibody associated with rheumatoid arthritis; useful in the evaluation of suspected RA and can be positive even before joint damage is visible on imaging.

Mutated Citrullinated Vimentin (MCV) Antibody

Measures antibodies targeting mutated citrullinated vimentin, a protein found in inflamed joint tissue. Useful for detecting RA and may help predict disease severity; used alongside symptoms, physical exam, imaging, and other blood tests.

RA (RHEUMATOID) FACTOR QUANTITATIVE

An antibody that may be present in rheumatoid arthritis, although it can also occur in other diseases and in some healthy individuals.

ERYTHROCYTE SEDIMENTATION RATE; ESR

Another commonly used marker of inflammation, often tracked over time alongside CRP.

C-REACTIVE PROTEIN (CRP) QUANTITATIVE

A marker of systemic inflammation that helps assess current inflammatory activity.

Most autoimmune antibody tests and inflammatory markers do not require fasting. However, if your doctor has ordered other tests at the same time — such as glucose or lipid testing — fasting may be required for those investigations. Please follow the preparation instructions provided by your doctor or NPL.

When to See a Doctor

  • Joint pain, swelling, or stiffness lasting more than six weeks

  • Symmetric involvement of multiple small joints (hands, wrists, feet)

  • Morning stiffness lasting longer than one hour

  • Joint symptoms accompanied by unexplained fatigue or low-grade fever

  • Difficulty performing daily tasks due to joint pain or reduced grip strength

  • Known RA with new or worsening symptoms despite treatment

Medical Disclaimer

Laboratory tests are supportive tools and should not be used alone to diagnose or exclude rheumatoid arthritis. Results should be interpreted by a qualified healthcare professional together with clinical history, physical examination, and imaging where appropriate.

Frequently Asked Questions

Anti-CCP is relatively specific for rheumatoid arthritis and is particularly useful when RA is suspected, but diagnosis still requires clinical assessment by a doctor.
Yes. Some patients with rheumatoid arthritis can have a negative RF (seronegative RA). Anti-CCP and clinical assessment may provide additional information in these cases.
No. Anti-CCP, RF, CRP, and ESR do not require fasting. If other tests are ordered alongside them, follow the preparation instructions provided by your doctor or NPL.
In some patients, inflammatory markers can be within the normal range despite active joint disease. Your doctor will interpret these results together with your symptoms and examination findings.
This depends on your treatment plan. Inflammatory markers (CRP, ESR) are often repeated periodically to monitor disease activity and treatment response, as advised by your doctor.